カテゴリー： Grand View Research, 世界, 医療/バイオ

バイオ医薬品3PL（サードパーティロジスティクス）の世界市場2023-2030：市場規模、シェア、動向分析

◆英語タイトル：Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが発行した調査報告書（GRV23AUG031）◆商品コード：GRV23AUG031
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2023年7月25日
◆ページ数：150
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

バイオ医薬品3PL（サードパーティロジスティクス）市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界のバイオ医薬品3PL（サードパーティロジスティクス）市場規模は2030年までに1985億米ドルに達する見込みです。同市場は、2023年から2030年にかけて年平均成長率6.0%で拡大する見込みです。様々な地域で生物製剤を輸送するための温度管理された物流サービスに対する需要の増加や、売上向上のためのバイオ医薬品企業の流通網の拡大が市場成長の要因となっています。新興国における自動保管・検索システムの採用の増加は、製薬ロジスティクス企業の間で進行中の傾向であり、大きな牽引力となっています。

さらに、低分子医薬品からワクチンや生物製剤を中心とするバイオ医薬品へのシフトが市場を牽引すると予測されています。これらの低分子医薬品は温度に敏感な製品であるため、温度管理された輸送と保管の需要が高まり、市場成長の要因となっています。技術的進歩は市場成長を促進する主な要因の一つです。モバイル・クラウド・ソリューション、倉庫ロボット工学、データマイニングなどの技術は、3PL空間全体を変えました。これらの先進技術の助けを借りて、3PL企業は、輸送中に製品の必要な温度を維持することができます。

これにより、製品の複雑さや人的ミスを減らすことができます。ほとんどのバイオ医薬品は非常に温度に敏感であるため、必要な温度で保管する必要があります。このような製品には、配送まで監視するための追跡装置が必要です。例えば、2023年5月、Tridentify社は、コールドチェーンで輸送される製品の安定性と残りの賞味期限を継続的に追跡する革新的な機能を備えたリアルタイムコールドチェーンモニタリングシステムを発売しました。このシステムは、医薬品の安定性と残存賞味期限をリアルタイムで詳細に把握できるため、企業の業務モニタリングや安定性予算の管理方法に革命をもたらすでしょう。

さらに、環境への配慮とコストにより、商用製品の輸送手段は、航空輸送から海上輸送へ、道路輸送はトラックから複合一貫輸送（鉄道とトラックの両方）へと、少しずつ変化しています。複合一貫輸送は、二酸化炭素排出量を削減するために、製薬会社が主に利用しています。現在進行中の傾向では、製薬会社はコストとリスク要因を削減するために海上輸送にシフトしています。コールドチェーン製品については、各社は依然として航空輸送を好んでいます。しかし、一部の大手製薬会社は、コールドチェーン製品を含め、製品の70%を海上輸送で輸送することを計画しています。

バイオ医薬品3PL（サードパーティロジスティクス）市場レポートハイライト

- 2022年、非コールドチェーン・ロジスティクス部門は、温度管理を必要としない医薬品の販売数が多いことから、売上高で79.7%の最大シェアを占めました。

- コールドチェーンロジスティクス分野は、細胞療法、ワクチン、検査キットなどの生物製剤の需要により、予測期間中にCAGR 8.8%を記録する見込みです。

- 倉庫・保管部門は2022年に43.3%の最大シェアを獲得しました。輸送部門も、企業の内部能力の不足により、2022年に大きな収益シェアを占めています。

- 北米は、バイオ医薬品の輸出入の増加により、2022年には42%超の最大収益シェアを占めました。

- アジア太平洋地域は、高齢化による医薬品の採用と、ブランドメーカーからジェネリックメーカーへの医薬品販売の移行により、予測期間中に最も速いCAGR 7.4%を記録する見込みです。

- 主要プレーヤーは、市場での存在感を高めるため、いくつかの戦略的な取り組みを行っています。例えば、2021年2月、Kuehne+Nagelは中国最大の非国営医薬品流通企業であるJointownとパートナーシップを締結し、中国におけるヘルスケアおよび医薬品ロジスティクスの足跡を強化しました。

第1章. 調査手法＆範囲
第2章. エグゼクティブサマリー
第3章. バイオ医薬品3PL（サードパーティロジスティクス）の市場変動・動向・範囲
第4章. バイオ医薬品3PL（サードパーティロジスティクス）市場：サービスタイプ別予測＆動向分析
第5章. バイオ医薬品3PL（サードパーティロジスティクス）市場：サプライチェーン別予測＆動向分析
第6章. バイオ医薬品3PL（サードパーティロジスティクス）市場：地域別予測＆動向分析
第7章. 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. Methodology
1.5. Research Scope and Assumptions
1.6. Market Formulation & Validation
1.6.1. COUNTRY MARKET: CAGR CALCULATION
1.7. Country Based Segment Share Calculation
1.8. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional Insights
2.4. Competitive Insights
2.5. Biopharmaceutical Third Party Logistics Market Snapshot
2.6. Biopharmaceutical Third Party Logistics Market Segment Snapshot
2.7. Biopharmaceutical Third Party Logistics Market Competitive Landscape Snapshot
Chapter 3. Biopharmaceutical Third Party Logistics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Biopharmaceutical Third-party Logistics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
Chapter 4. Biopharmaceutical Third-party Logistics Market: Service Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Biopharmaceutical Third-party Logistics Market: Service Movement Analysis, USD Billion, 2022 & 2030
4.3. Transportation
4.3.1. Transportation Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
4.3.2. Air Freight
4.3.2.1. Air Freight Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
4.3.3. Sea Freight
4.3.3.1. Sea Freight Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
4.3.4. Overland Transportation
4.3.4.1. Overland Transportation Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
4.4. Warehousing & Storage
4.4.1. Warehousing & Storage Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
4.5. Others
4.5.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 5. Biopharmaceutical Third Party Logistics Market: Supply Chain Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biopharmaceutical Third Party Logistics Market: Supply Chain Movement Analysis, USD Billion, 2022 & 2030
5.3. Cold Chain
5.3.1. Cold Chain Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
5.4. Non-Cold Chain
5.4.1. Non-Cold Chain Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 6. Biopharmaceutical Third Party Logistics Market: Regional Estimates & Trend Analysis
6.1. Biopharmaceutical Third Party Logistics Market: Regional Movement Analysis, 2022 & 2030
6.2. North America
6.2.1. North America Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.2.2. Regulatory Framework
6.2.3. U.S.
6.2.3.1. Key Country Dynamics
6.2.3.2. Competitive Scenario
6.2.3.3. U.S. Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.2.4. Canada
6.2.4.1. Key Country Dynamics
6.2.4.2. Competitive Scenario
6.2.4.3. Canada Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.3. Europe
6.3.1. Europe Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.3.2. Regulatory Framework
6.3.3. UK
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. UK Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.3.4. Germany
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Germany Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.3.5. France
6.3.5.1. Key Country Dynamics
6.3.5.2. Competitive Scenario
6.3.5.3. France Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.3.6. Italy
6.3.6.1. Key Country Dynamics
6.3.6.2. Competitive Scenario
6.3.6.3. Italy Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.3.7. Spain
6.3.7.1. Key Country Dynamics
6.3.7.2. Competitive Scenario
6.3.7.3. Spain Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.3.8. Denmark
6.3.8.1. Key Country Dynamics
6.3.8.2. Competitive Scenario
6.3.8.3. Denmark Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.3.9. Sweden
6.3.9.1. Key Country Dynamics
6.3.9.2. Competitive Scenario
6.3.9.3. Sweden Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.3.10. Norway
6.3.10.1. Key Country Dynamics
6.3.10.2. Competitive Scenario
6.3.10.3. Norway Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.4. Asia Pacific
6.4.1. Asia Pacific Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.4.2. Regulatory Framework
6.4.3. Japan
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Japan Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.4.4. China
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. China Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.4.5. India
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. India Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.4.6. Australia
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Australia Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.4.7. Thailand
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Thailand Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.4.8. South Korea
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. South Korea Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.5. Latin America
6.5.1. Latin America Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.5.2. Regulatory Framework
6.5.3. Brazil
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Brazil Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Mexico Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.5.5. Argentina
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Argentina Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.6. Middle East & Africa
6.6.1. Middle East & Africa Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.6.2. Regulatory Framework
6.6.3. South Africa
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. South Africa Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.6.4. Saudi Arabia
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Saudi Arabia Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.6.5. UAE
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. UAE Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
6.6.6. Kuwait
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Kuwait Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Share Analysis, 2022
7.3. List of Key Private Players
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. DHL International GmbH
7.5.1.1. Overview
7.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. SF Express
7.5.2.1. Overview
7.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. United Parcel Service of America, Inc.
7.5.3.1. Overview
7.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. AmerisourceBergen Corp.
7.5.4.1. Overview
7.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. DB Schenker
7.5.5.1. Overview
7.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Kuehne and Nagel
7.5.6.1. Overview
7.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Kerry Logistics Network Ltd.
7.5.7.1. Overview
7.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Agility
7.5.8.1. Overview
7.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 4. Global Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 5. Global Biopharmaceutical Third-party Logistics Market by Region, 2018 - 2030 (USD Billion)
Table 6. North America Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
Table 7. North America Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 8. North America Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 9. U.S. Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 10. U.S. Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 11. Canada Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 12. Canada Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 13. Europe Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
Table 14. Europe Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 15. Europe Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 16. Germany Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 17. Germany Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 18. UK Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 19. UK Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 20. France Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 21. France Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 22. Italy Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 23. Italy Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 24. Spain Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 25. Spain Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 26. Denmark Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 27. Denmark Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 28. Sweden Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 29. Sweden Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 30. Norway Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 31. Norway Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 32. Asia Pacific Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
Table 33. Asia Pacific Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 34. Asia Pacific Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 35. China Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 36. China Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 37. Japan Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 38. Japan Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 39. India Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 40. India Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 41. South Korea Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 42. South Korea Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 43. Australia Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 44. Australia Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 45. ThailandBiopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 46. ThailandBiopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 47. Latin America Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
Table 48. Latin America Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 49. Latin America Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 50. Brazil Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 51. Brazil Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 52. Mexico Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 53. Mexico Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 54. Argentina Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 55. Argentina Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 56. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
Table 57. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 58. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 59. South Africa Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 60. South Africa Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 61. Saudi Arabia Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 62. Saudi Arabia Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 63. UAE Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 64. UAE Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
Table 65. Kuwait Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 66. Kuwait Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ バイオ医薬品3PL（サードパーティロジスティクス）の世界市場2023-2030：市場規模、シェア、動向分析(Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 医療用チューブの世界市場2024-2030：市場規模、シェア、動向分析
  • 遺伝子合成（研究用）の世界市場2023-2030：市場規模、シェア、動向分析
  • 衛星通信（SATCOM）の世界市場2023-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆